Vir Biotechnology Inc (VIR)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	-587,165	-684,305	833,068	276,891	-296,980
Revenue	US$ in thousands	74,205	86,180	1,580,470	1,087,070	76,368
Operating profit margin		-791.27%	-794.04%	52.71%	25.47%	-388.88%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $-587,165K ÷ $74,205K
= -791.27%

Vir Biotechnology Inc's operating profit margin has experienced significant fluctuations over the years. In December 2020, the operating profit margin was a very concerning -388.88%, indicating that the company's operating expenses exceeded its revenues by a substantial margin. However, by December 2021, the operating profit margin had improved to a positive 25.47%, suggesting that the company was able to generate operating profit relative to its revenue.

Subsequently, in December 2022, the operating profit margin further improved to a robust 52.71%, reflecting a significant increase in operational efficiency and profitability. However, in the following years, the operating profit margins took a sharp downturn. By December 2023 and 2024, the operating profit margins were highly negative at -794.04% and -791.27% respectively, indicating that the company's operating expenses far exceeded its revenues, leading to substantial operating losses.

Overall, the analysis suggests that while Vir Biotechnology Inc was able to achieve positive operating profit margins in some years, the company also faced challenges in managing its operating expenses effectively, resulting in significant losses in other periods.